[
  {
    "ts": "2025-11-24T11:00:42+00:00",
    "headline": "AbbVie Insiders Sell US$41m Of Stock, Possibly Signalling Caution",
    "summary": "In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...",
    "url": "https://finance.yahoo.com/news/abbvie-insiders-sell-us-41m-110042518.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4b76f256-433e-3bb7-8481-86e022e2c85c",
      "content": {
        "id": "4b76f256-433e-3bb7-8481-86e022e2c85c",
        "contentType": "STORY",
        "title": "AbbVie Insiders Sell US$41m Of Stock, Possibly Signalling Caution",
        "description": "",
        "summary": "In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...",
        "pubDate": "2025-11-24T11:00:42Z",
        "displayTime": "2025-11-24T11:00:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-insiders-sell-us-41m-110042518.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-insiders-sell-us-41m-110042518.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T10:09:00+00:00",
    "headline": "The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc",
    "summary": "JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-jpmorgan-netflix-100900358.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1a660740-3221-3044-aeb5-17062dfa405c",
      "content": {
        "id": "1a660740-3221-3044-aeb5-17062dfa405c",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc",
        "description": "",
        "summary": "JPM shows solid operational strength as analysts highlight its NII outlook, fee pressures and expense trajectory through 2027.",
        "pubDate": "2025-11-24T10:09:00Z",
        "displayTime": "2025-11-24T10:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ec5e634237cc9eabea4779690f3efeeb",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RTx3Nu58__O03ev86DmrHg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ec5e634237cc9eabea4779690f3efeeb.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P1dL6a_GH1zJjKxkuy3PlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ec5e634237cc9eabea4779690f3efeeb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-jpmorgan-netflix-100900358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-jpmorgan-netflix-100900358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "OVBC"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "NFLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T13:00:00+00:00",
    "headline": "AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference",
    "summary": "AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.",
    "url": "https://finance.yahoo.com/news/abbvie-present-piper-sandler-37th-130000951.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "ea9cb043-84c9-39d6-a71d-86fb338d4607",
      "content": {
        "id": "ea9cb043-84c9-39d6-a71d-86fb338d4607",
        "contentType": "STORY",
        "title": "AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) will participate in the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025. Management will participate in a fireside chat at 7:30 a.m. Central time.",
        "pubDate": "2025-11-24T13:00:00Z",
        "displayTime": "2025-11-24T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559",
          "originalWidth": 400,
          "originalHeight": 70,
          "caption": "AbbVie logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g0d6LyVLzKGBfCQ5BSCPww--~B/aD03MDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559.cf.webp",
              "width": 400,
              "height": 70,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IUj902SDWZLhwmCbmJBNXA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a5eaa0af5f515703fe951de405417559.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-piper-sandler-37th-130000951.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-piper-sandler-37th-130000951.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:56:10+00:00",
    "headline": "Investors bet on newer technology and indications for CGTs",
    "summary": "The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in vivo CAR-Ts.",
    "url": "https://www.pharmaceutical-technology.com/news/investors-bet-on-newer-technology-and-indications-for-cgts/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "5830a720-dec2-3f9f-b0d7-5d5b69fdf914",
      "content": {
        "id": "5830a720-dec2-3f9f-b0d7-5d5b69fdf914",
        "contentType": "STORY",
        "title": "Investors bet on newer technology and indications for CGTs",
        "description": "",
        "summary": "The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in vivo CAR-Ts.",
        "pubDate": "2025-11-24T12:56:10Z",
        "displayTime": "2025-11-24T12:56:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/6f19608ca9160d3a63d17ab115804d0a",
          "originalWidth": 2560,
          "originalHeight": 1556,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_0M74bouJyARZzoWZw8qBw--~B/aD0xNTU2O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/pharmaceutical_technology_376/6f19608ca9160d3a63d17ab115804d0a.cf.webp",
              "width": 2560,
              "height": 1556,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YkLvnXOF3Y3O4rAwQ3PGeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/6f19608ca9160d3a63d17ab115804d0a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/investors-bet-on-newer-technology-and-indications-for-cgts/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-bet-newer-technology-indications-125610689.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T12:25:00+00:00",
    "headline": "5 Dividend Stocks to Hold for the Next 10 Years",
    "summary": "Investors should be able to count on steady dividends from these great stocks.",
    "url": "https://www.fool.com/investing/2025/11/24/5-dividend-stocks-to-hold-for-the-next-10-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "3a93487a-9506-391e-9c54-d4fc28c80c01",
      "content": {
        "id": "3a93487a-9506-391e-9c54-d4fc28c80c01",
        "contentType": "STORY",
        "title": "5 Dividend Stocks to Hold for the Next 10 Years",
        "description": "",
        "summary": "Investors should be able to count on steady dividends from these great stocks.",
        "pubDate": "2025-11-24T12:25:00Z",
        "displayTime": "2025-11-24T12:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2608d9e3b974a40bf24f03b4692ad3eb",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Icons surrounding the word \"Dividend\" appearing above a laptop with a person's hands reaching out.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7NpVRW1CFW45Ng.qAoqg1Q--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2608d9e3b974a40bf24f03b4692ad3eb.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zBKWwgj_c1f756Lg6QISdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2608d9e3b974a40bf24f03b4692ad3eb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/24/5-dividend-stocks-to-hold-for-the-next-10-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-dividend-stocks-hold-next-122500268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T18:09:51+00:00",
    "headline": "Full FDA Approval of EPKINLY Combo Therapy Could Be a Game Changer for AbbVie (ABBV)",
    "summary": "AbbVie recently received full FDA approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide for the treatment of adults with relapsed or refractory follicular lymphoma, following robust Phase 3 results showing significant improvement over standard of care. This landmark regulatory milestone addresses an unmet need in a challenging lymphoma type, potentially expanding AbbVie's reach in oncology and advancing treatment standards for patients with limited...",
    "url": "https://finance.yahoo.com/news/full-fda-approval-epkinly-combo-180951374.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "74ded5f5-b64c-3a19-b581-f407415eab76",
      "content": {
        "id": "74ded5f5-b64c-3a19-b581-f407415eab76",
        "contentType": "STORY",
        "title": "Full FDA Approval of EPKINLY Combo Therapy Could Be a Game Changer for AbbVie (ABBV)",
        "description": "",
        "summary": "AbbVie recently received full FDA approval for EPKINLY (epcoritamab-bysp) in combination with rituximab and lenalidomide for the treatment of adults with relapsed or refractory follicular lymphoma, following robust Phase 3 results showing significant improvement over standard of care. This landmark regulatory milestone addresses an unmet need in a challenging lymphoma type, potentially expanding AbbVie's reach in oncology and advancing treatment standards for patients with limited...",
        "pubDate": "2025-11-24T18:09:51Z",
        "displayTime": "2025-11-24T18:09:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/full-fda-approval-epkinly-combo-180951374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/full-fda-approval-epkinly-combo-180951374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-24T22:05:07+00:00",
    "headline": "How Recent Developments Are Shaping Analyst Views on AbbVie’s Future Edge",
    "summary": "Analysts have recently nudged AbbVie's consensus price target upward, rising slightly from $241.29 to $243.55 as updated sentiment filters through the market. This shift reflects increased optimism driven by strong performance in key growth areas and strategic business moves. Stay tuned to find out how investors can stay informed on evolving perspectives and future updates in AbbVie’s dynamic story. Analyst Price Targets don't always capture the full story. Head over to our Company Report to...",
    "url": "https://finance.yahoo.com/news/recent-developments-shaping-analyst-views-220507519.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1cb08d9b-831f-3bfb-a591-a9e2d9ed45f9",
      "content": {
        "id": "1cb08d9b-831f-3bfb-a591-a9e2d9ed45f9",
        "contentType": "STORY",
        "title": "How Recent Developments Are Shaping Analyst Views on AbbVie’s Future Edge",
        "description": "",
        "summary": "Analysts have recently nudged AbbVie's consensus price target upward, rising slightly from $241.29 to $243.55 as updated sentiment filters through the market. This shift reflects increased optimism driven by strong performance in key growth areas and strategic business moves. Stay tuned to find out how investors can stay informed on evolving perspectives and future updates in AbbVie’s dynamic story. Analyst Price Targets don't always capture the full story. Head over to our Company Report to...",
        "pubDate": "2025-11-24T22:05:07Z",
        "displayTime": "2025-11-24T22:05:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-shaping-analyst-views-220507519.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-shaping-analyst-views-220507519.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]